Yamamoto, Noboru
Fujiwara, Yutaka
Tamura, Kenji
Kondo, Shunsuke
Iwasa, Satoru
Tanabe, Yuko
Horiike, Atsushi
Yanagitani, Noriko
Kitazono, Satoru
Inatani, Michiyasu
Tanaka, Jun
Nishio, Makoto
Article History
Received: 31 July 2016
Accepted: 5 August 2016
First Online: 27 August 2016
Compliance with ethical standards
:
: This study was supported by Chugai Pharmaceutical Co., Ltd. (Tokyo, Japan). Medical writing assistance and editing was provided by Macmillan Medical Communications (Tokyo, Japan), and funded by Chugai Pharmaceutical Co., Ltd.
: Noboru Yamamoto has received research grants from Chugai Pharmaceutical, Eli Lilly, Taiho, Eisai, Quintiles, Astellas Pharma, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, Boehringer-Ingelheim, Kyowa-Hakko Kirin, and Bayer.Yutaka Fujiwara has received research grants from AstraZeneca, Daiichi Sankyo, Chugai Pharmaceutical, Eisai, Eli Lilly, MSD, and Merck Serono.Kenji Tamura has received research grants from Chugai Pharmaceutical, AstraZeneca, Daiichi Sankyo, Eisai, MSD, Eli Lilly, Pfizer, AbbVie and Byer.Shunsuke Kondo has received research grants from Bayer, AstraZeneca, and Eli Lilly.Satoru Iwasa has no conflicts of interest to declare.Yuko Tanabe has no conflicts of interest to declare.Atsushi Horiike has no conflicts of interest to declare.Noriko Yanagitani is an advisory board member of Chugai Pharmaceutical.Satoru Kitazono has no conflicts of interest to declare.Michiyasu Inatani and Jun Tanaka are employee of Chugai Pharmaceutical.Makoto Nishio has received research grants from Novartis, Ono Pharmaceutical, Chugai Pharmaceutical, Bristol-Myers Squibb, Taiho Pharmaceutical, Eli Lilly, Pfizer, Astellas Pharma, and AstraZeneca, and honoraria from Pfizer, Bristol-Myers Squibb, Ono Pharmaceutical, Chugai Pharmaceutical, Eli Lilly, Taiho Pharmaceutical, and AstraZeneca.
: The study was conducted in accordance with the Declaration of Helsinki, the Pharmaceutical Affairs Law, and Good Clinical Practice. The study protocol was approved by the Institutional Review Boards of the participating institutions.
: Written informed consent was obtained from all patients included in the study.